185 related articles for article (PubMed ID: 20530667)
1. High-mobility group A1 proteins regulate p53-mediated transcription of Bcl-2 gene.
Esposito F; Tornincasa M; Chieffi P; De Martino I; Pierantoni GM; Fusco A
Cancer Res; 2010 Jul; 70(13):5379-88. PubMed ID: 20530667
[TBL] [Abstract][Full Text] [Related]
2. High-mobility group A1 inhibits p53 by cytoplasmic relocalization of its proapoptotic activator HIPK2.
Pierantoni GM; Rinaldo C; Mottolese M; Di Benedetto A; Esposito F; Soddu S; Fusco A
J Clin Invest; 2007 Mar; 117(3):693-702. PubMed ID: 17290307
[TBL] [Abstract][Full Text] [Related]
3. High-mobility group A1 protein inhibits p53-mediated intrinsic apoptosis by interacting with Bcl-2 at mitochondria.
Esposito F; Tornincasa M; Federico A; Chiappetta G; Pierantoni GM; Fusco A
Cell Death Dis; 2012 Aug; 3(8):e383. PubMed ID: 22932725
[TBL] [Abstract][Full Text] [Related]
4. High Mobility Group A1 (HMGA1) proteins interact with p53 and inhibit its apoptotic activity.
Pierantoni GM; Rinaldo C; Esposito F; Mottolese M; Soddu S; Fusco A
Cell Death Differ; 2006 Sep; 13(9):1554-63. PubMed ID: 16341121
[TBL] [Abstract][Full Text] [Related]
5. Brn-3a transcription factor blocks p53-mediated activation of proapoptotic target genes Noxa and Bax in vitro and in vivo to determine cell fate.
Hudson CD; Morris PJ; Latchman DS; Budhram-Mahadeo VS
J Biol Chem; 2005 Mar; 280(12):11851-8. PubMed ID: 15598651
[TBL] [Abstract][Full Text] [Related]
6. A minimal Bcl-x promoter is activated by Brn-3a and repressed by p53.
Sugars KL; Budhram-Mahadeo V; Packham G; Latchman DS
Nucleic Acids Res; 2001 Nov; 29(22):4530-40. PubMed ID: 11713302
[TBL] [Abstract][Full Text] [Related]
7. Negative regulation of beta4 integrin transcription by homeodomain-interacting protein kinase 2 and p53 impairs tumor progression.
Bon G; Di Carlo SE; Folgiero V; Avetrani P; Lazzari C; D'Orazi G; Brizzi MF; Sacchi A; Soddu S; Blandino G; Mottolese M; Falcioni R
Cancer Res; 2009 Jul; 69(14):5978-86. PubMed ID: 19567674
[TBL] [Abstract][Full Text] [Related]
8. The Brn-3a transcription factor inhibits the pro-apoptotic effect of p53 and enhances cell cycle arrest by differentially regulating the activity of the p53 target genes encoding Bax and p21(CIP1/Waf1).
Budram-Mahadeo V; Morris PJ; Latchman DS
Oncogene; 2002 Sep; 21(39):6123-31. PubMed ID: 12203124
[TBL] [Abstract][Full Text] [Related]
9. HMGA1 inhibits the function of p53 family members in thyroid cancer cells.
Frasca F; Rustighi A; Malaguarnera R; Altamura S; Vigneri P; Del Sal G; Giancotti V; Pezzino V; Vigneri R; Manfioletti G
Cancer Res; 2006 Mar; 66(6):2980-9. PubMed ID: 16540646
[TBL] [Abstract][Full Text] [Related]
10. Distinct promoter elements mediate the co-operative effect of Brn-3a and p53 on the p21 promoter and their antagonism on the Bax promoter.
Perez-Sanchez C; Budhram-Mahadeo VS; Latchman DS
Nucleic Acids Res; 2002 Nov; 30(22):4872-80. PubMed ID: 12433990
[TBL] [Abstract][Full Text] [Related]
11. Role of p53 and NF-kappaB in epigallocatechin-3-gallate-induced apoptosis of LNCaP cells.
Hastak K; Gupta S; Ahmad N; Agarwal MK; Agarwal ML; Mukhtar H
Oncogene; 2003 Jul; 22(31):4851-9. PubMed ID: 12894226
[TBL] [Abstract][Full Text] [Related]
12. Expression of bcl-2, c-erbB-2, p53, and p21 (waf1-cip1) protein in thyroid carcinomas.
Soda G; Antonaci A; Bosco D; Nardoni S; Melis M
J Exp Clin Cancer Res; 1999 Sep; 18(3):363-7. PubMed ID: 10606183
[TBL] [Abstract][Full Text] [Related]
13. p53 mediates bcl-2 phosphorylation and apoptosis via activation of the Cdc42/JNK1 pathway.
Thomas A; Giesler T; White E
Oncogene; 2000 Nov; 19(46):5259-69. PubMed ID: 11077443
[TBL] [Abstract][Full Text] [Related]
14. Spiro-oxindole derivative 5-chloro-4',5'-diphenyl-3'-(4-(2-(piperidin-1-yl) ethoxy) benzoyl) spiro[indoline-3,2'-pyrrolidin]-2-one triggers apoptosis in breast cancer cells via restoration of p53 function.
Saxena R; Gupta G; Manohar M; Debnath U; Popli P; Prabhakar YS; Konwar R; Kumar S; Kumar A; Dwivedi A
Int J Biochem Cell Biol; 2016 Jan; 70():105-17. PubMed ID: 26556313
[TBL] [Abstract][Full Text] [Related]
15. Survivin up-regulates the expression of breast cancer resistance protein (BCRP) through attenuating the suppression of p53 on NF-κB expression in MCF-7/5-FU cells.
Wang QP; Wang Y; Wang XD; Mo XM; Gu J; Lu ZY; Pan ZL; Zhu YX
Int J Biochem Cell Biol; 2013 Sep; 45(9):2036-44. PubMed ID: 23838170
[TBL] [Abstract][Full Text] [Related]
16. Conjugated linoleic acids (CLAs) regulate the expression of key apoptotic genes in human breast cancer cells.
Majumder B; Wahle KW; Moir S; Schofield A; Choe SN; Farquharson A; Grant I; Heys SD
FASEB J; 2002 Sep; 16(11):1447-9. PubMed ID: 12205043
[TBL] [Abstract][Full Text] [Related]
17. Analysis of bcl-2 in sporadic breast carcinoma.
Dueñas-González A; Abad-Hernández MM; Cruz-Hernández JJ; González-Sarmiento R
Cancer; 1997 Dec; 80(11):2100-8. PubMed ID: 9392332
[TBL] [Abstract][Full Text] [Related]
18. Indirect p53-dependent transcriptional repression of Survivin, CDC25C, and PLK1 genes requires the cyclin-dependent kinase inhibitor p21/CDKN1A and CDE/CHR promoter sites binding the DREAM complex.
Fischer M; Quaas M; Nickel A; Engeland K
Oncotarget; 2015 Dec; 6(39):41402-17. PubMed ID: 26595675
[TBL] [Abstract][Full Text] [Related]
19. The high-mobility group A1a/signal transducer and activator of transcription-3 axis: an achilles heel for hematopoietic malignancies?
Hillion J; Dhara S; Sumter TF; Mukherjee M; Di Cello F; Belton A; Turkson J; Jaganathan S; Cheng L; Ye Z; Jove R; Aplan P; Lin YW; Wertzler K; Reeves R; Elbahlouh O; Kowalski J; Bhattacharya R; Resar LM
Cancer Res; 2008 Dec; 68(24):10121-7. PubMed ID: 19074878
[TBL] [Abstract][Full Text] [Related]
20. Induction of apoptosis by p53, bax, bcl-2, and p21 expressed in colorectal cancer.
Katsumata K; Sumi T; Tomioka H; Aoki T; Koyanagi Y
Int J Clin Oncol; 2003 Dec; 8(6):352-6. PubMed ID: 14663636
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
